Severe neutrophilic asthma, autoimmune diseases, i.e. rheumatoid arthritis, systemic sclerosis.
Severe neutrophilic asthma, autoimmune diseases, i.e. rheumatoid arthritis, systemic sclerosis.
FB704A is a fully human monoclonal antibody that inhibits IL-6/IL-6R signaling pathway by neutralizing IL-6. IL-6 pathway has emerged as a pivotal pathway involved in immune regulation in many cancers and immune disorders.
Ref:
1. Source: Literature Review, Frost & Sullivan Analysis
2. European Respiratory Journal 2018 52: PA3918
3. The Potential American Market for Generic Biological Treatments and the Associated Cost Savings
http://www.sonecon.com/docs/studies/0208_GenericBiologicsStudy.pdf
Research Code | Therapeutic Area | Indication | Pre-Clinical | Phase I | Phase II | Phase III | NDA | Market | More |
---|
FB704A is a fully human monoclonal antibody that inhibits IL-6/IL-6R signaling pathway by neutralizing IL-6. IL-6 pathway has emerged as a pivotal pathway involved in immune regulation in many cancers and immune disorders.
建議您使用以下瀏覽器觀看合一網站,
以獲得最佳瀏覽效果。
如何使用IE找到Microsoft Edge?